Delivery Order SPE2DR25D1017-SPE2DR26F8YUS
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,944.66 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order awarded without any set-aside designation, reflecting a competitively awarded...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 26, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 3 mg/0.5 mL pens with a ceiling value of $6,006.00. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025. The contract is not set-aside and represents a competitive award under the company's existing indefinite delivery contract vehicle with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,128.98 for Trulicity 0.75 mg/0.5 mL pens by the Defense Logistics Agency Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and was competitively awarded without set-aside provisions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $11,940.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 3 mg/0.5 ml pen injections, valued at $1,641.36, with an ultimate completion date of July 22, 2025. The contract was competitively awarded on July 21, 2025, using firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a single pharmaceutical procurement under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,858.72. This competitive award, issued without a set-aside designation, carries a firm fixed price structure with an ultimate completion date of July 24, 2025. The product will be performed and distributed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,702.70 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order is for Trulicity 1.5 mg/0.5 ml pen injectables and was issued under a firm fixed-price, non-set-aside competitive contract. This child delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml) with a ceiling value of $1,041.84. This is a firm fixed price, non-competitive delivery order funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8YUSDelivery Order
AmerisourceBergen Drug Corp was awarded a firm fixed price delivery order valued at $1,788.24 by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL). The contract, which represents a non-competitive set-aside delivery, is scheduled for completion by October 31, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse therapeutic needs, from specialty medications and branded drugs to vaccines and medical devices. This specific delivery order for Trulicity—an injectable diabetes medication—exemplifies the company's role in providing essential pharmaceutical commodities through the DLA's medical supply chain to support Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/30/25 |